RxDoctor Payments Data

Maurice Alisse, PA

Physician Assistant · Newburgh, NYNPI 1730130386

Payments from drug & device makers

$16,048in general payments, 2019–2025

Across 840 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$2K
  • AbbVie$2K
  • AstraZeneca$1K
  • Amgen$1K
  • GSK$1K
  • Pfizer$850
  • plus $8K from 52 others

What the payments were for

  • Food & beverage$15,91199%
  • Education$1371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC131$2,045
AbbVie76$1,598
AstraZeneca57$1,467
Amgen63$1,077
GSK55$1,043
Pfizer47$850
Boehringer Ingelheim30$635
Bayer26$628
Otsuka America Pharmaceutical, Inc.25$626
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$454
Novo Nordisk20$359
Novartis23$349
Teva Pharmaceuticals USA, Inc.16$338
E.r. Squibb & Sons, L.L.C.20$332
Regeneron Healthcare Solutions, Inc.9$332
Amarin Pharma, Inc.25$331
Takeda Pharmaceuticals U.S.A., Inc.15$327
Sanofi17$307
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)13$277
Amneal Pharmaceuticals LLC16$272
Exact Sciences11$223
Kowa Pharmaceuticals America, Inc.14$216
Axsome Therapeutics, Inc.8$188
Mylan Specialty L.p.7$169
Astellas Pharma US Inc6$135
Biohaven Pharmaceuticals, Inc.9$123
Antares Pharma, Inc.6$110
Lundbeck LLC5$95
Currax Pharmaceuticals LLC5$92
Medtronic4$90
Phathom Pharmaceuticals, Inc.4$90
Abbott5$77
Paratek Pharmaceuticals, Inc.4$77
Viatris Specialty LLC3$64
Esperion Therapeutics, Inc.3$58
Biohaven Pharmaceutical Holding Company Ltd.3$50
Johnson & Johnson3$49
Xeris Pharmaceuticals, Inc.2$46
Avanir Pharmaceuticals, Inc.2$45
Corcept Therapeutics2$39
Merck2$37
Vistapharm, Inc.2$36
Halozyme Inc2$32
Arbor Pharmaceuticals, Inc.2$29
Argenx US, Inc.1$23
Endo Pharmaceuticals Inc.1$21
Pulmonx Corporation1$19
Inspire Medical Systems, Inc.1$19
Vanda Pharmaceuticals Inc.1$19
Redhill Biopharma Inc.1$19
CSL Behring1$19
Biodelivery Sciences International, Inc.1$18
Jazz Pharmaceuticals Inc.1$15
Mannkind Corporation1$14
Biogen1$13
Nabriva Therapeutics, PLC1$13
Idorsia Pharmaceuticals US Inc1$12
Genentech USA, Inc.1$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,048 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$128,994
Medicare patients
267
Services billed
3,456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide118$127,734
EliquisApixaban104$123,257
OzempicSemaglutide60$85,886
Trelegy ElliptaFluticasone/Umeclidin/Vilanter82$63,493
JardianceEmpagliflozin32$49,175
LinzessLinaclotide57$41,711
TrulicityDulaglutide18$35,430
XifaxanRifaximin11$31,466
RybelsusSemaglutide27$25,526
FarxigaDapagliflozin Propanediol26$24,459
RexultiBrexpiprazole14$22,933
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/712$20,212
Repatha SureclickEvolocumab15$16,185
Aimovig AutoinjectorErenumab-Aooe13$11,507
TrintellixVortioxetine Hydrobromide21$10,724

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$2,045$163,163136 claims
PfizerEliquis$850$123,257104 claims
Novo NordiskOzempic, Rybelsus$359$111,41287 claims
GSKTrelegy Ellipta$1,043$63,49382 claims
Boehringer IngelheimJardiance$635$49,17532 claims
AbbVieLinzess$1,598$41,71157 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,467$34,56643 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$454$31,46611 claims
Otsuka America Pharmaceutical, Inc.Rexulti$626$22,93314 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$327$10,72421 claims
Redhill Biopharma Inc.Movantik$19$6,75812 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$272$2,351163 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Newburgh

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →